Atypical neuroleptic malignant syndrome with quetiapine: A case report and review of the literature

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 497-499

  El Gaaly, Sherief ^a   St John, Philip ^a   Dunsmore, Sara ^a   Bolton, James M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DANTROLENE; QUETIAPINE;

ADULT; AGITATION; ANAMNESIS; AUDITORY HALLUCINATION; BEHAVIOR CHANGE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; ELECTROCONVULSIVE THERAPY; HUMAN; HYPERTENSION; INSOMNIA; LETTER; MAJOR DEPRESSION; MALE; MUSCLE RIGIDITY; MUSCLE TONE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; SPEECH DISORDER; SUICIDAL IDEATION; TACHYCARDIA; TREMOR;

ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 70349675179     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b4b091     Document Type: Letter

References (20)

1. Caroff SN, Mann SC, Campbell EC. Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann. 2000;30:314-321.
2. Picard LS, Lindsay S, Strawn JR, et al. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy. 2008;28:530-535.
3. Buckley PF, Hasan S. Atypical neuroleptic malignant syndrome and atypical antipsychotics. Am J Psychiatry. 1998;155:1633.
4. Solomons K. Quetiapine and neuroleptic malignant syndrome. Can J Psychiatry. 2002;47:791.
5. Bourgeois J, Babine S, Meyerovich M, et al. A case of neuroleptic malignant syndrome with quetiapine. J Neuropsychiatry Clin Neurosci. 2002;14:87.
6. Whalley N, Diaz P, Howard J. Neuroleptic malignant syndrome associated with the use of quetiapine. Can J Hospital Pharmacy. 1999;52:112.
7. Choi-Kain L, Pope H. BAtypical neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes. Harv Rev Psychiatry. 2007;15:181-186.
8. Stanley AK, Hunter J. Possible neuroleptic malignant syndrome with quetiapine. Br J Psychiatry. 2000;176:497.
9. Bora E, Gonul A, Akdeniz F, et al. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy. Eur Psychiatry. 2003;18:322-323.
10. Kobayashi A, Kawanishi C, Matsumura T, et al. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: A case report. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1170-1172.
11. Grignon S, Brethes JI, Chamberland M, et al. Incipient neuroleptic malignant syndrome with quetiapine/paroxetine combination treatment: Atypical presentation and early, successful rechallange with olanzapine. Int J Psychiatr Clin Pract. 2005;9:296-298.
12. Matsumoto R, Kitabayashi Y, Nakatomi Y, et al. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine. Am J Psychiatry. 2005;162:812.
13. Sing K, Ramaekers G, Van Harten P. Neuroleptic malignant syndrome and quetiapine. Am J Psychiatry. 2002; 159:149-150.
14. Al-Waneen R. Neuroleptic malignant syndrome associated with quetiapine. Can J Psychiatry. 2000;45:764-765.
15. Hatch CD, Lund BC, Perry PJ. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics. Pharmacotherapy. 2001; 21:1003-1006.
16. Farver DK. Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opin Drug Saf. 2003;2:21-35.
17. Karagianis JL, Phillips LC, Hogan KP, et al. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature. Ann Pharmacother. 1999; 33:623-630.
18. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164:870-876.
19. Marlowe K, Schirgel D. Quetiapine and citalopram: Aetiological significance in serotonin syndrome. N Z Med J. 2006; 119:2058-2060.
20. Stevens DL. Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome. Ann Pharmacother. 2008;42:1290-1297.